Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
COVID 19 Diagnosis Analysis using Transfer Learning
Coronaviruses, including SARS-CoV-2, are responsible for COVID-19, a highly transmissible disease that emerged in December 2019 in Wuhan, China. During the past five years, significant advancements have been made in understanding and mitigating the virus. Although the initial outbreak led to global health crises, improved vaccination strategies, antiviral treatments, and AI-driven diagnostic tools have contributed to better disease management. However, COVID-19 continues to pose risks, particularly for immuno-compromised individuals and those with pre-existing conditions. This study explores the use of deep learning for a rapid and accurate diagnosis of COVID-19, addressing ongoing challenges in healthcare infrastructure and testing accessibility. We propose an enhanced automated detection system leveraging state-of-the-art convolutional neural networks (CNNs), including updated versions of VGG16, VGG19, and ResNet50, to classify COVID-19 infections from chest radiographs and computerized tomography (CT) scans. Our results, based on an expanded dataset of over 6000 medical images, demonstrate that the optimized ResNet50 model achieves the highest classification performance, with 97.77% accuracy, 100% sensitivity, 93.33% specificity, and a 98.0% F1-score. These findings reinforce the potential of AI-assisted diagnostic tools in improving early detection and pandemic preparedness.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.